๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combined thiotepa and mitomycin C instillation therapy for low-grade superficial bladder tumor

โœ Scribed by Kang-Ning Hu; Albert Kim; Ali S. Khan; Harry Soroff; Maurice Gonder

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
544 KB
Volume
55
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Sequential instillation therapy with mit
Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors
โœ Iwao Fukui; Hideaki Sekine; Kazunori Kihara; Takumi Yamada; Tsuneo Kawai; Makoto ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 346 KB

From October 1983 to September 1985, 84 patients with superficial bladder tumor (Ta, Tl, Tis) were treated with sequential instillation of mitomycin C (MMC) and adriamycin (ADM). Doses of 20 mg MMC on day 1 and 40 mg ADM on day 2 were instilled into the bladder and retained for at least 2 h; this wa

Prophylactic intravesical instillation t
Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer
โœ Tomoyasu Tsushima; Yosuke Matsumura; Yujiro Ozaki; Jun Yoshimoto; Hiroyuki Ohmor ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 380 KB

Intravesical instillation of adriamycin (ADM) or mitomycin C (MMC) was carried out for the purpose of preventing the recurrence of superficial bladder cancers (Ta and T1) after transurethral resection or transurethral coagulation. First, eligible patients were divided into two groups (solitary and m

Combination therapy with mitomycin C, 5-
Combination therapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside for nonresectable malignant tumor in man
โœ Takayuki Yamaguchi; Masanori Nakamura ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 672 KB

The effectiveness of MFC (mitomycin C, 5-fluorouracil and cytosine arabinoside) therapy for nonresectable cancers and cancers recurring after surgery was investigated in 60 patients with solid cancers aged 26 to 69 years. Treatment was effective in 28 patients (47%) including seven (12%) who showed